Low molecular weight heparins (LMWHs) are now the mainstay option in the prevention and treatment of venous thromboembolism. In some patients receiving therapeutic doses of LMWH, activity can be measured by quantifying the presence of Anti-factor Xa (AFXa) for dose adjustment. However, currently there are no guidelines for LMWH monitoring in patients on thromboprophylactic, doses,…
Hematology Reports Template
Write in a clean editor, then format for Hematology Reports in one click — DocuGuru applies the official MDPI template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Hematology Reports format
Hematology Reports is a peer-reviewed journal published by MDPI, covering Acute Myeloid Leukemia Research, Lymphoma Diagnosis and Treatment, Hemoglobinopathies and Related Disorders. Over its lifetime it has published 666 papers, which have received 4,625 citations.
| Publisher | MDPI |
|---|---|
| Reference style | Numbered (MDPI) Numbered — [1], [2] in the text 1. Smith, A.; Jones, B.; Lee, C. A Representative Article Title. Hematology Reports 2023, 12, 45–58.
Formats any DOI in Hematology Reports style. No sign-up. |
| Abbreviation (ISO-4) | Hematol. Rep. |
| Publishes research in | Acute Myeloid Leukemia Research Lymphoma Diagnosis and Treatment Hemoglobinopathies and Related Disorders Chronic Lymphocytic Leukemia Research Multiple Myeloma Research and Treatments |
| ISSN | 2038-8322 |
| Citation impact (2-yr) | 2.07 |
| h-index | 30 |
| i10-index | 152 |
| Article processing charge | $1,082 |
| Open access | Yes — indexed in DOAJ |
| Top institutions publishing here | Istituti di Ricovero e Cura a Carattere Scientifico |
| Journal website | www.mdpi.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Hematology Reports per year
Citation impact of Hematology Reports by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Hematology Reports
Sickle Cell Disorder (SCD) is a congenital hemoglobinopathy. There is little in literature regarding the psychological variables affecting individuals living with SCD and all of the significant people around them. There are also limited numbers of trained clinical psychologists and genetic counselors to cater for the psychotherapeutic needs of individuals living with SCD. Even among…
Atypical hemolytic uremic syndrome (aHUS) is a disease characterized by the triad of microangiopathic hemolytic anemia, thrombocytopenia and acute kidney injury. The histopathologic lesions of aHUS include thrombotic microangiopathy involving the glomerular capillaries and thrombosis involving arterioles or interlobar arteries. Extra-renal manifestations occur in up to 20% of patients. The majority of aHUS is caused…
Menin inhibitors are new and promising agents currently in clinical development that target the HOX/MEIS1 transcriptional program which is critical for leukemogenesis in histone-lysine N-methyltransferase 2A-rearranged (KMT2Ar) and in NPM1-mutated (NPM1mut) acute leukemias. The mechanism of action of this new class of agents is based on the disruption of the menin-KMT2A complex (consisting of chromatin…
Coronavirus disease 2019 (COVID-19) increases the risk of thromboembolic events, especially in patients with severe infections requiring intensive care and cardiorespiratory support. COVID-19 patients with thromboembolic complications have a higher risk of death, and if they survive, these complications are expected to negatively affect these patients' quality of life. Moreover, recent data reported that the…